BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20250916T042642EDT-2295zuMmUu@132.216.98.100 DTSTAMP:20250916T082642Z DESCRIPTION:The Genesis of the COVID Vaccine: The Path to the Nobel Prize\n \nFeaturing Nobel Laureate Dr. Drew Weissman\n\nVaccination has perhaps be en the most significant advance in the history of medicine. Smallpox\, a d eadly disease\, has been totally eradicated\, while polio\, mumps\, measle s and rubella have been effectively curbed. The development of vaccines ma kes for a fascinating story exemplified by the path that led to the introd uction of the life-saving COVID-19 vaccine. As is often the case with rese arch\, serendipity\, rejection\, grit and determination all played a role in forging that path culminating in the awarding of a Nobel Prize to Dr. D rew Weissman and colleague Dr. Katalin Kariko.\n\nThe path to success is n ever a straight shot—it’s paved with occasional potholes and many unexpect ed detours. The trick is to not allow the “bumps” along the way to stifle one's curiosity or extinguish one's passion. Even perceived failures infor m next steps and every now and then the road offers up something magical a nd unexpected. Dr. Weissman's story began with a fiercely innate curiosity about the world in which he was surrounded. This curiosity fuelled his in terest in science and he spent decades in obscurity\, toiling away at a la b bench. What put Dr. Weissman on the road to the formulation of a world-w ide life-saving vaccine and the Nobel? Luck? Grit? Or a little of both?\n \nRegister today to attend the 2025 Trottier Public Science Symposium with Dr. Drew Weissman \n\nThis symposium will be recorded and made available post-event on the 9I Office of Science and Society website.\n\n\nAbout the Speaker\n\n\n\nDrew Weissman\, MD\, PhD\, is the Roberts Family Profe ssor in Vaccine Research and director of the Penn Institute for RNA Innova tion at the Perelman School of Medicine. He is recognized for his work alo ngside Katalin Karikó in discovering the modified mRNA technology\, which has launched a new era of vaccine and therapeutic development.\n\nTheir mR NA research breakthrough has been used in both the BioNTech/Pfizer and Mod erna COVID-19 vaccines and has revolutionized the field of vaccine develop ment. Dr. Weissman’s current research focuses on developing a pan-coronavi rus vaccine to stop the next coronavirus epidemic\, a universal flu vaccin e\, cancer therapeutics\, a vaccine to prevent herpes\, as well as develop ing in vivo gene therapy to allow worldwide use and a variety of protein t herapeutics delivered with mRNA-LNPs. He has recently expanded his efforts in building scientific and medical equity and is developing the full RNA- LNP ecosystem of development\, testing\, and use in low and middle-income countries.\n\nDr. Weissman earned bachelor’s and master’s degrees in bioch emistry and enzymology from Brandeis University in 1981 and his M.D. and P h.D. in immunology and microbiology in 1987 at Boston University School of Medicine. Following a residency at Beth Israel Hospital in Boston\, he to ok a fellowship at the National Institutes of Health\, where he worked wit h Dr. Anthony Fauci.\n\nDr. Weissman holds many patents and has published over 400 papers. He has been recognized with numerous awards\, including t he Lasker-DeBakey Clinical Medical Research Award\, the Breakthrough Prize in Life Sciences\, the Albany Medical Center Prize in Medicine and Biomed ical Research\, and the Nobel Prize in Medicine or Physiology.\n DTSTART:20251021T230000Z DTEND:20251022T003000Z LOCATION:Room 132\, Leacock Building\, CA\, QC\, Montreal\, H3A 2T7\, 855 r ue Sherbrooke Ouest SUMMARY:2025 Trottier Public Science Symposium URL:/research/channels/event/2025-trottier-public-scie nce-symposium END:VEVENT END:VCALENDAR